State Street Corp Acadia Pharmaceuticals Inc Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 6,178,044 shares of ACAD stock, worth $157 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,178,044
Previous 6,993,513
11.66%
Holding current value
$157 Million
Previous $116 Million
14.72%
% of portfolio
0.01%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding ACAD
# of Institutions
345Shares Held
164MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$1.09 Billion9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$388 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$307 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$229 Million2.98% of portfolio
-
Morgan Stanley New York, NY4.11MShares$105 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $4.12B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...